Risk factor
Poor trading liquidity
Profitability factor
Solid dividends
About
Formosa Laboratories, Inc. operates as a worldwide manufacturer and distributor of active pharmaceutical ingredients (APIs). The company supplies a diverse range of APIs, catering to therapeutic areas such as oncology, pain and inflammation management, MRI contrast enhancement, cholesterol and phosphate regulation, central nervous system conditions, immune system modulation, respiratory disorders, and also provides steroids, vitamin D derivatives, and antibiotics. In addition to its API production, Formosa Laboratories offers extensive contract development and manufacturing services, specializing in solutions for antibody-drug conjugate (ADC) production and injectable formulations. This Taiwan-based company, headquartered in Taoyuan City, was founded in 1995.
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. In particular, the stock is reasonably priced on P/E, 'cheap' on EV/EBIT
Target Price
The average target price of 4746.TW is 106 and suggests 102% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc